본문 바로가기
KERD
논문KCI 등재

역류성식도염 유발 흰쥐에 대한 二陳湯加味方의 효과

Effects of Yijintang-gamibang on Reflux Esophagitis Induced by Pylorus and Forestomach Ligation in Rat

곽민아|임소연|변준석|김대준|김희준
대한한방내과학회 (The Society Of Korean Oriental Internal Medicine)|2010.03|대한한방내과학회지 (The Journal of Korean Oriental Internal Medicine)|제31권 제1호|pp. 128-141

2

조회

0

다운로드

15

인용

0

참고문헌

키워드

Reflux EsophagitisYijintang-gamibangOmeprazole
주제분류한의학

초록

Purpose : The object of this study was to observe the suppressive effects of Yijintang-gamibang (YJGMB), Yijintang with Atractylodis Rhizoma, Massa Medicata Fermentata, Hordei Fructus Germiniatus, and Coptidis Rhizoma. YJGMB has been traditionally used in Korean medicine for treating various digestive diseases. We tested it on the rat reflux esophagitis (RE) induced by pylorus and forestomach ligation in rats as compared with omeprazole, a well-known proton pump inhibitor. Method : Three different dosages of YJGMB 200, 100 and 50㎎/㎏, were orally pretreated once a day for 28 days before pylorus and forestomach ligation. Seven groups, each of 8 rats per group were used in the study. Six hours after pylorus and forestomach ligation, changes of the stomach and esophagus lesion areas, gastric volumes, acid and pepsin outputs, invasive lesion percentages, fundic mucosa and total thicknesses were measured as histomorphometry. The results were compared with omeprazole, antioxidant and proton pump inhibitor, and 30 and 10㎎/㎏ treated groups in which the effects on RE were already confirmed. Results : As results of pylorus and forestomach ligation, marked increases of esophageal and gastric mucosa lesion areas, gastric volumes, acid outputs, pepsin outputs were observed with histopathological changes of RE, such as hemorrhages, ulcerative lesions and edematous changes on the fundic mucosa. However, these pylorus and forestomach ligation-induced RE were dose-dependently inhibited by treatment of 200, 100 and 50㎎/㎏ of YJGMB. YJGMB 200㎎/㎏ showed similar protective effects as compared with 30㎎/㎏ of omeprazole in the present study, and more favorable effects were observed in 50㎎/㎏ of YJGMB treated rats as compared with omeprazole 10㎎/㎏ in the present study. Conclusion : The results obtained in this study suggest that YJGMB has favorable protective effects on the RE induced by pylorus and forestomach ligation. Therefore, it is expected that YJGMB will also show favorable effects on RE corresponding well to the suggestion of traditional Korean medicine. However, more detailed mechanism studies should be conducted in future with the screening of the biological active chemical compounds in herbs.

Abstract

Purpose : The object of this study was to observe the suppressive effects of Yijintang-gamibang (YJGMB), Yijintang with Atractylodis Rhizoma, Massa Medicata Fermentata, Hordei Fructus Germiniatus, and Coptidis Rhizoma. YJGMB has been traditionally used in Korean medicine for treating various digestive diseases. We tested it on the rat reflux esophagitis (RE) induced by pylorus and forestomach ligation in rats as compared with omeprazole, a well-known proton pump inhibitor. Method : Three different dosages of YJGMB 200, 100 and 50㎎/㎏, were orally pretreated once a day for 28 days before pylorus and forestomach ligation. Seven groups, each of 8 rats per group were used in the study. Six hours after pylorus and forestomach ligation, changes of the stomach and esophagus lesion areas, gastric volumes, acid and pepsin outputs, invasive lesion percentages, fundic mucosa and total thicknesses were measured as histomorphometry. The results were compared with omeprazole, antioxidant and proton pump inhibitor, and 30 and 10㎎/㎏ treated groups in which the effects on RE were already confirmed. Results : As results of pylorus and forestomach ligation, marked increases of esophageal and gastric mucosa lesion areas, gastric volumes, acid outputs, pepsin outputs were observed with histopathological changes of RE, such as hemorrhages, ulcerative lesions and edematous changes on the fundic mucosa. However, these pylorus and forestomach ligation-induced RE were dose-dependently inhibited by treatment of 200, 100 and 50㎎/㎏ of YJGMB. YJGMB 200㎎/㎏ showed similar protective effects as compared with 30㎎/㎏ of omeprazole in the present study, and more favorable effects were observed in 50㎎/㎏ of YJGMB treated rats as compared with omeprazole 10㎎/㎏ in the present study. Conclusion : The results obtained in this study suggest that YJGMB has favorable protective effects on the RE induced by pylorus and forestomach ligation. Therefore, it is expected that YJGMB will also show favorable effects on RE corresponding well to the suggestion of traditional Korean medicine. However, more detailed mechanism studies should be conducted in future with the screening of the biological active chemical compounds in herbs.

참고문헌 (45)

  1. Kahrilas PJ, "Clinical esophageal pH recording: a technical review for practice guideline development", Gastroenterology, 110, pp.1982~1996 (1996)
  2. Vigneri S, "A comparison of five maintenance therapies for reflux esophagitis", N Engl J Med, 333, pp.1106~1110 (1995)
  3. Harris RA, "Prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis of maintenance proton pump inhibitation", Am J Med, 102, pp.78~88 (1997)
  4. Kawano S, "Randomized comparative study of omeprazole and famotidine in reflux esophagitis", J Gastroenterol Hepatol, 17, pp.955~959 (2002)
  5. 윤형란, "역류성 식도염 치료에 대한 양자펌프억제제와 ranitidine 사용의 비용-효과 분석", 대한내과학회지, 62(5), pp.3~512 (2002), 대한내과학회
  6. Marks RD, "Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis", Gastroenterology, 106, pp.907~915 (1994)
  7. Dent J, "Omeprazole vs ranitidine for prevention of relapse in reflux oesophagitis", A controlled double blind trial of their efficacy and safety. Gut., 35, pp.590~598 (1994)
  8. McKeage K, "Esomeprazole: a review of its use in the management of gastric acid-related diseases in adults", Drugs., 68, pp.1571~1607 (2008)
  9. DeVault KR, "Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease", Am J Gastroenterol, 1434~1440 (1994)
  10. 허준, "동의보감", pp.2135~2137 (2005), 법인문화사
  11. 장태수, "二陳湯의 鎭痛, 鎭痙消炎 및 Gastrin과 Uropepsin의 分泌에 미치는 影響", 석사, pp.1982
  12. 최정우, "二陳湯 煎湯液이 흰쥐 胃의 Gastrin, histamine, somatostatin 免疫反應細胞에 미치는 影響", 석사, pp.2001
  13. 한숙영, "二陳湯이 정상 및 위 유문부가 부분폐색된 흰 쥐의 위 운동성에 미치는 효과", 대한한방내과학회지, 30(1), pp.107~118 (2009), 대한한방내과학회
  14. 배동주, "생쥐의 胃粘膜 損傷에 대한 二陳湯, 四君子湯 및 六君子湯의 比較 硏究", 박사, pp.2005
  15. 황지영, "역류성 식도염에 대한 二陳湯加味方 효과 연구", 동의생리병리학회지, 23(5), pp.1073~1079 (2009), 대한동의병리학회
  16. "Department of Health, Education, and Welfare Publication (National Institute of Health)", 85~123 (1985)
  17. Rao CV, "Effect of quercetin, flavonoids and alpha-tocopherol, an antioxidant vitamin on experimental reflux esophagitis in rats", Eur J Pharmacol, 589, pp.233~238 (2008)
  18. Nakamura K, "Effects of sodium polyacrylate (PANa) on acute esophagitis by gastric juice in rats", Jpn J Pharmacol., 32, pp.445~456 (1982)
  19. Nagahama K, "Protective effect of lafutidine, a novel H2- receptor antagonist, on reflux esophagitis in rats through capsaicin-sensitive afferent neurons", J Pharmacol Sci., 93, pp.55~61 (2003)
  20. Sairam K, "Antiulcerogenic effect of methanolic extract of Emblica officinalis: an experimental study", J Ethnopharmacol., 82, pp.1~9 (2002)
  21. 전국한의과대학 비계내과학 교수, "비계내과학", pp.57~58 (2000), 한성기획
  22. 김동현, "한방약리학", pp.49~ (2006), 신일상사
  23. 신정인, "黃連의 Helicobacter pylori에 대한 항균 효과", 대한한방내과학회지, 24(2), pp.269~282 (2003)
  24. 이은방, "항궤양약 및 진경약의 약효검색", 한국응용약물학회 신약개발 연구발표회 초록집, 1, pp.46~ (1992)
  25. Bicakci U, "Effects of omeprazole and gentamicin on the biochemical and histopathological alterations of the hypoxia", reoxygenation induced intestinal injury in newborn rats, 2005, pp.21, 800~805
  26. Katada K, "Prevention by rebamipide of acute reflux esophagitis in rats", Dig Dis Sci., 50, pp.97~103 (2005)
  27. Young Sil Min, "The Effect of Luteolin-7-O-β-D-Glucuronopyranoside on Gastritis and Esophagitis in Rats", Archives of Pharmacal Research, 29(6), pp.31~31 (2006), 대한약학회
  28. Duarte CG, "The effect of the antithyroid drug propylthiouracil on the alternative pathway of complement in rats", Int J Immunopharmacol, 22, pp.25~33 (2000)
  29. Pinzone Fox ML, "Plasma leptin concentration increases early during highly active antiretroviral therapy for acquired immunodeficiency syndrome, independent of body weight", J Endocrinol Invest, 28, pp.1~3 (2005)
  30. Chang HH, "A novel immunomodulatory protein from Poria cocos induces Toll-like receptor 4-dependent activation within mouse peritoneal macrophages", J Agric Food Chem, 57, pp.6129~6139 (2009)
  31. Chan WK, "Response of human dendritic cells to different immunomodulatory polysaccharides derived from mushroom and barley", Int Immunol., 19, pp.891~899 (2007)
  32. Cheng A, "Macrophage immunomodulatory activity of polysaccharides isolated from Glycyrrhiza uralensis Fish", Int Immunopharmacol., 8, pp.43~50 (2008)
  33. DeMeester TR, "Clinical and in vitro analysis of determinants of gastroesophageal competence: a study of the principles of antireflux surgery", Am J Surg., 137, pp.39~46 (1979)
  34. Hunt RH, "Importance of pH control in the management of GERD", Arch Intern Med, 159, pp.649~657 (1999)
  35. Meuwissen SGM, "Treatment of reflux oesophagitis with H2-receptor antagonist", Scand J Gastroenterol., 23(Suppl 146), pp.201~213 (1988)
  36. Klinkenberg-Knol EC, "Use of omeprazole in the management of reflux oesophagitis resistant to H2-receptor antagonists", Scand J Gastroenterol, 24(Suppl 166), pp.88~93 (1989)
  37. Inatomi N, "Effects of a proton pump inhibitor, AG-1749 (lansoprazole), on reflux esophagitis and experimental ulcers in rats", Jpn J Pharmacol, 55, pp.437~451 (1991)
  38. Gartner LP, "Color Textbook of Histology", pp.381~411 (2007), Elsevier
  39. Katz PO, "Lessons learned from intragastric pH monitoring", J Clin Gastroenterol, 33, pp.107~113 (2001)
  40. Orlando RC, "Pathogenesis of gastroesophageal reflux disease", Am J Med Sci, 326, pp.274~278 (2003)
  41. Castell DO, "Review article: the pathophysiology of gastro-oesophageal reflux disease - oesophageal manifestations", Aliment Pharmacol Ther, 20(Suppl 9), pp.14~25 (2004)
  42. Wang C, "Precise role of acid in non-erosive reflux disease", Digestion, 78(Suppl 1), pp.31~41 (2008)
  43. Pera M, "Duodenal-content reflux esophagitis induces the development of glandular metaplasia and adenosquamous carcinoma in rats", Carcinogenesis, 21, pp.1587~1591 (2000)
  44. Kim JM, "Combined use of omeprazole and a novel antioxidative cytoprotectant for the treatment of peptic ulcer. Facilitation of ulcer healing in experimental animals", Arzneimittelforschung, 55, pp.387~393 (2005)
  45. Kuroiwa Y, "Enhancement of esophageal carcinogenesis in acid reflux model rats treated with ascorbic acid and sodium nitrite in combination with or without initiation", Cancer Sci., 99, pp.7~13 (2008)

관련 논문AI추천

역류성 식도염에 대한 二陳湯加味方 효과 연구김대준, 변준석, 황지영한의병리학회 · 동의생리병리학회지2009 · 제23권 제5호逆流性 食道炎에 대한 二陳湯加味方 構成 個別 한약재의 效果곽민아, 이상태대한한방내과학회 · 대한한방내과학회지2013 · 제34권 제2호二陳湯加味方의 항산화 효과를 통한 역류성 식도염 억제효과박경, 곽민아, 김대준, 변준석한의병리학회 · 동의생리병리학회지2010 · 제24권 제3호增味二陳湯 투여가 역류성 식도염 유발 생쥐에 미치는 영향이슬기, 임성우대한한방내과학회 · 대한한방내과학회지2016 · 제37권 제6호좌금환이 역류성 식도염 흰쥐에 미치는 영향김의수, 김태련, 신민구, 이영수, 임현찬대한한방내과학회 · 대한한방내과학회지2016 · 제37권 제3호역류성 식도염 유발 흰쥐에 대한 유근피 추출물의 억제 효과김의수, 신만호, 이영수한의병리학회 · 동의생리병리학회지2016 · 제30권 제4호

이 간행물의 다른 논문 (15건)

한국표준질병사인분류중 한방내과영역의 분류체계 개선 및 진단명 구성에 관한 연구이원철pp. 1-10枳椇子 山靑木 配合이 D-galactosamine 유발 백서의 간손상에 미치는 影響문구, 이선아pp. 11-24消平湯이 RIN-m5F 세포에서 인슐린 분비 및 유전자 발현에 미치는 영향조충식, 윤성식pp. 25-39진전 변증에 관한 문헌적 고찰 - 중국 논문 중심으로 -선승호pp. 40-53Glutamate로 유도된 C6 glial 세포 자멸사에 대한 淸心蓮子飮의 보호효과권오상, 하예진, 이선아, 고석재, 안민섭, 신용진, 장원석, 신선호pp. 54-65
원문 보기